SEC Urged to Ban Complex Derivatives Following South Korea Market Meltdown
Former Goldman Sachs analyst warns structured retail products pose systemic risks to U.S. markets.
Pressure is mounting on the U.S. Securities and Exchange Commission to prohibit high-risk structured derivative products sold to retail investors following a severe financial market disruption in South Korea linked to similar instruments.
The development underscores growing apprehension among financial engineering specialists over the expansion of complex structured notes into retail investment portfolios. Derivatives experts warn that without intervention by the SEC, product structures capable of triggering automated selling cascades could replicate overseas market shocks within American capital markets.
Nic Puckrin, a former Goldman Sachs derivatives structuring analyst in the firm’s Investment Banking Division and founder of market research platform Coin Bureau, argued that regulatory authorities must move to ban the products behind South Korea’s recent market meltdown before similar structural failures occur in U.S. markets. Puckrin, who holds an MSc in Financial Engineering from Imperial College London, spent over a decade across traditional finance and digital asset markets.
South Korea’s financial sector experienced severe turbulence after complex equity-linked derivatives and structured financial products suffered rapid devaluation, triggering mandatory liquidations and sharp market declines. Similar financial instruments in the U.S. fall under the regulatory jurisdiction of the Securities and Exchange Commission, which oversees public offerings of leveraged products and exotic exchange-traded funds.
The financial products in question typically incorporate embedded derivative options that offer higher yields during stable market conditions but impose severe downside losses when underlying asset price thresholds are breached. Regulatory filings indicate that retail participation in derivative-linked notes and leveraged financial products has expanded significantly across major international exchanges over the past decade.
U.S. regulatory authorities have previously issued public suitability guidance regarding complex leveraged and inverse products, though federal rules currently allow their public distribution under standardized disclosure requirements.
